Skip to content

Opening book details…

Can I read NLRP3 Inflammasome Biomarker—Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome on EtoBox?

NLRP3 Inflammasome Biomarker—Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome by Suceveanu, Andra-Iulia; Mazilu, Laura; Katsiki, Niki; Parepa, Irinel; Voinea, Felix; Pantea-Stoian, Anca; Rizzo, Manfredi; Botea, Florin; Herlea, Vlad; Serban, Dragos; Suceveanu, Adrian-Paul is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is NLRP3 Inflammasome Biomarker—Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome about?

Metabolomics, the research area studying chemical processes involving metabolites, finds its utility in inflammasome biomarker discovery, thus representing a novel approach for cardiometabolic syndrome pathogeny acknowledgements. Metabolite biomarkers discovery is expected to improve the disease evolution and outcome. The activation of abundantly expressed NLRP3 inflammasome represents the background process of the diabetes mellitus disturbances like hyperglycemia and insulin resistance, as well as for myocardial cell death and fibrosis, all of them being features characteristic for cardiometabolic syndrome. Many molecules like troponins, brain natriuretic protein (BNP), ST2/IL-33, C-reactive protein (CRP), TNF, IL-1β, and IL-18 cytokines have been already examined as molecular markers for diagnosing or predicting different cardiac disturbances like myocardial infarction, heart failure, or myocarditis. In addition, metabolomics research comes with new findings arguing that NLRP3 inflammasome becomes a promising molecular tool to use for clinical and therapeutical management providing new targets for therapies in cardiometabolic syndrome. Inflammasome markers analyses, along with ot

Who reads NLRP3 Inflammasome Biomarker—Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Suceveanu, Andra-Iulia; Mazilu, Laura; Katsiki, Niki; Parepa, Irinel; Voinea, Felix; Pantea-Stoian, Anca; Rizzo, Manfredi; Botea, Florin; Herlea, Vlad; Serban, Dragos; Suceveanu, Adrian-Paul
Publisher
MDPI AG; Multidisciplinary Digital Publishing Institute (MDPI); Basel: MDPI AG, 2011- (ISSN 2218-1989)
Published
2020
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Suceveanu, Andra-Iulia; Mazilu, Laura; Katsiki, Niki; Parepa, Irinel; Voinea, Felix; Pantea-Stoian, Anca; Rizzo, Manfredi; Botea, Florin; Herlea, Vlad; Serban, Dragos; Suceveanu, Adrian-Paul

Browse all works by Suceveanu, Andra-Iulia; Mazilu, Laura; Katsiki, Niki; Parepa, Irinel; Voinea, Felix; Pantea-Stoian, Anca; Rizzo, Manfredi; Botea, Florin; Herlea, Vlad; Serban, Dragos; Suceveanu, Adrian-Paul